May 2026
📣 VC round data is live. Check it out!
Largest Nutraceuticals & Cosmeceuticals Public Companies in China
Benchmark revenue and EBITDA valuation multiples for public comps like
Zhejiang NHU, Yunnan Baiyao Group, Imeik Technology Development, a2 Milk and Chengzhi.
 | Zhejiang Nhu Co Ltd is a China-based company engaged in the manufacture and sales of pharmaceuticals, health protection products, pharmaceutical intermediates, fragrances, food additives, and feed additives. The company's active pharmaceutical ingredient products cover various areas such as Cardiovascular, Anti-AIDS, Anti-cancer, and Anti-bacterial, with key products such as Latamoxef Sodium, Flomoxef Sodium, Hydrochloride Moxifloxacin, Artemisinin series, Calcium Keto acid series, Vitamin A/E/D3, and coenzyme Q10, and others. The other business areas are Aroma chemicals, Polymers, and Nutrition. The organization markets its products in China and internationally. | $5 | +60% | $16B | $15B | 4.6x | 9.9x | ||
| Yunnan Baiyao Group Co Ltd is engaged in the manufacturing and marketing of medicines, which include herbal products, daily health products, raw medicine, drug classics, and others. | $8 | -5% | $14B | $12B | 2.0x | 12.6x | ||
| Imeik Technology Development is a leading Chinese medical aesthetics company, best known for its portfolio of hyaluronic acid-based solutions and gel injectable products. Founded in 2004 and headquartered in Beijing, the company has built its reputation on product innovation and a differentiated strategy, enabling it to rank first in China with a market share by value exceeding 20% in 2024. In 2025, Imeik acquired a controlling stake (approximately 60%) in South Korea’s Regen Biotech through a joint venture with an investment fund. Presently, almost all of Imeik’s revenue is derived domestically in China. | $17 | -32% | $5B | $5B | 12.7x | 19.7x | ||
| A2 Milk is a New Zealand licensor and marketer of fresh milk, infant formula, and other dairy products that lack the A1 beta-casein protein. The firm was founded in 2000 by Corran McLachlan, who developed a genetic test to determine which proteins a cow produces in its milk, and business partner Howard Paterson. The company has been through a tumultuous history of receivership, legal battles, and strategic shifts, but emerged in its current structure in 2006 and listed publicly in March 2013. | $5 | -20% | $3B | $3B | 2.6x | 15.5x | ||
| Chengzhi Co Ltd, formerly Chengzhi Shareholding Co Ltd is a China-based company engaged in the businesses of clean energy, functional materials and medical care and health. | $2 | +65% | $2B | $3B | 1.6x | 19.9x | ||
| Beijing Scitop Bio-tech Co Ltd is engaged in production and sales of compound food additives, edible probiotic products and animal and plant micro-ecological preparations. The company engages in provision of biotechnology services, consulting, development, transfer; development and sale of stereotyped packaged food additives, compound food additives. Its products include Probio-M8 and Probio-M9. | $3 | +12% | $689M | $582M | 10.9x | 28.8x | ||
| Zhejiang Shouxiangu Pharmaceutical Co Ltd is a Chinese pharmaceutical company. | $3 | -25% | $508M | $433M | 4.6x | 13.5x | ||
| Median | $5 | -5% | $3B | $3B | 4.6x | 15.5x |
Financial data powered by FactSet and Morningstar. Valuation multiples as of current fiscal year. For more data, start your free trial here.
Recent Insights
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.